Earnings (Loss) Per Share Data

3 Months Ended

Mar. 31, 2015

Earnings Per Share [Abstract]

Earnings (Loss) Per Share Data

The following is a reconciliation of the basic and diluted earnings per share (“EPS”) computations for both the numerator and denominator (in thousands, except per share data):

	Three months ended March 31,
2015:	Income (Numerator)		Common Shares(Denominator)	Per Common Share Amounts
Basic EPS
Income from continuing operations	$	77,389		$	0.80
Loss from discontinued operations	—			—
Net income	$	77,389	96,721	$	0.80
Effect of Dilutive Securities
Convertible securities	66		6,028
Stock options, units and awards	—		446
Diluted EPS
Income from continuing operations plus assumed conversions	$	77,455		$	0.75
Loss from discontinued operations	—			—
Net income plus assumed conversions	$	77,455	103,195	$	0.75
	Three months ended March 31,
2014:	Income (Numerator)		Common Shares(Denominator)	Per Common Share Amounts
Basic EPS
Income from continuing operations	$	63,638		$	0.65
Income from discontinued operations	136			—
Net income	$	63,774	98,566	$	0.65
Effect of Dilutive Securities
Convertible securities	66		8,463
Stock options, warrants, units and awards	—		738
Diluted EPS
Income from continuing operations plus assumed conversions	$	63,704		$	0.59
Income from discontinued operations	136			—
Net income plus assumed conversions	$	63,840	107,767	$	0.59

EPS is reported independently for each amount presented. Accordingly, the sum of the individual amounts may not necessarily equal the separately calculated amounts for the corresponding period.

The Company is required to include additional shares in its diluted shares outstanding calculation based on the treasury stock method when the average market price of a share of Omnicare common stock on the New York Stock Exchange for the applicable period exceeds the following amounts:

Convertible Debt	Price
3.75% convertible senior subordinated notes, due 2025	$	26.56
4.00% junior subordinated convertible debentures, due 2033	$	40.82
3.25% convertible senior debentures, due 2035	$	77.00
3.25% convertible senior exchange debentures, due 2035	$	77.00
3.50% convertible senior subordinated notes, due 2044	$	70.00

Diluted weighted average shares outstanding for the three months ended March 31, 2015 and 2014 excludes the impact of an immaterial number of stock options and stock awards with exercise prices that are greater than the average fair market value of the Company’s common stock during the applicable period.